Long-term results of splenectomy in primary myelofibrosis

L. M. Meshcheryakova; Мещерякова Л. М.; L. G. Kovaleva; Ковалева Л. Г.; S. R. Karagyulyan; Карагюлян С. Р.; L. Yu. Kolosova; Колосова Л. Ю.; O. V. Porotkova; Пороткова О. В.; Ye. A. Semenova; Семенова Е. А.

doi:10.17650/1818-8346-2013-8-1-40-45

Long-term results of splenectomy in primary myelofibrosis

Authors: Meshcheryakova L.M.¹, Kovaleva L.G.¹, Karagyulyan S.R.¹, Kolosova L.Y.¹, Porotkova O.V.², Semenova Y.A.¹
Affiliations:
1. Hematologic Scientific Center, Ministry of Health of Russia
2. Voronezh Regional Clinical Hospital № 1
Issue: Vol 8, No 1 (2013)
Pages: 40-45
Section: HEMATOLOGIC MALIGNANCIES: DIAGNOSIS, TREATMENT, SUPPORTIVE CARE
Published: 22.02.2013
URL: https://oncohematology.abvpress.ru/ongm/article/view/42
DOI: https://doi.org/10.17650/1818-8346-2013-8-1-40-45
ID: 42

Cite item

Full Text

Abstract
About the authors
References
Supplementary files
Statistics

Abstract

The estimation of immediate and long-term results after splenectomy depending on indications and contra-indications for 18 primary myelofibrosis (PMF) patients was shown. The reduction of intra- and postoperative complications in PMF patients was noted if the operation was
performed under strict indications and also with prophylactic heparin therapy. Life expectancy is extended after splenectomy during subsequent
relevant specific treatment.